首页 > 最新文献

Asian Journal of Research in Pharmaceutical Sciences最新文献

英文 中文
A Review on Emulgel: Improvement of Topical Absorption of Drug 乳凝胶:促进药物局部吸收的研究进展
Pub Date : 2022-11-22 DOI: 10.52711/2231-5659.2022.00057
A. Shinde, A. Velhal, P. Jadhav, V. Redasani
Emulgel is a developing topical drug delivery technique that, if more attempt is put for the preparations with majority of topically effective drugs, will be a benefit for dermal care and cosmetic products due to its dual release control system (gel and emulsion). The direct availability of the skin as a target organ for diagnosis and treatment is a distinguishing characteristic of dermatological pharmacology. Transparent gels have grown in popularity as a crucialclass of semisolid preparations in both cosmetics and pharmaceuticals. Despite the many benefits of gels, one major limitation is the delivery of water insoluble drugs because solubility acts as a barricade and a problem arises during drug release. As a result, an emulsion-based strategy is being employed to bypass this barrier, allowing even a hydrophobic medicinal component to benefit from the special features of gels. Emulgels are dosage forms made up of gels and emulsions that have been mixed. The major goal is to generate a jellified emulsion that will reduce systemic side effects and produce a more prominent effect with fewer drug doses. Thixotropic, greaseless, good Spreadability, easily removable, soothing, soluble in water, long shelf life, bio-friendly, translucent & appealing look are only a few of the benefits of emulgels for dermatological use. As a result, emulgels can be utilize as a good topical drug delivery mechanism than the currently existing traditional systems.
乳凝胶是一种正在发展的外用药物给药技术,如果对大多数外用有效药物的制剂进行更多的尝试,由于其双重释放控制系统(凝胶和乳液),将有利于皮肤护理和化妆品。皮肤作为诊断和治疗的靶器官的直接可用性是皮肤药理学的一个显著特征。透明凝胶作为化妆品和药品中一类重要的半固体制剂越来越受欢迎。尽管凝胶有许多好处,但一个主要的限制是水不溶性药物的输送,因为溶解度起着障碍作用,在药物释放过程中会出现问题。因此,一种基于乳化的策略被用来绕过这一屏障,甚至允许疏水的药物成分受益于凝胶的特殊功能。凝胶是由凝胶和乳剂混合而成的剂型。主要目标是产生一种凝胶状乳剂,以减少全身副作用,并以更少的药物剂量产生更显著的效果。触变性,无油,良好的涂抹性,易于拆卸,舒缓,可溶于水,保质期长,生物友好,半透明和吸引人的外观只是皮肤病学使用乳液的一些好处。因此,与目前现有的传统系统相比,凝胶可以作为一种良好的局部给药机制。
{"title":"A Review on Emulgel: Improvement of Topical Absorption of Drug","authors":"A. Shinde, A. Velhal, P. Jadhav, V. Redasani","doi":"10.52711/2231-5659.2022.00057","DOIUrl":"https://doi.org/10.52711/2231-5659.2022.00057","url":null,"abstract":"Emulgel is a developing topical drug delivery technique that, if more attempt is put for the preparations with majority of topically effective drugs, will be a benefit for dermal care and cosmetic products due to its dual release control system (gel and emulsion). The direct availability of the skin as a target organ for diagnosis and treatment is a distinguishing characteristic of dermatological pharmacology. Transparent gels have grown in popularity as a crucialclass of semisolid preparations in both cosmetics and pharmaceuticals. Despite the many benefits of gels, one major limitation is the delivery of water insoluble drugs because solubility acts as a barricade and a problem arises during drug release. As a result, an emulsion-based strategy is being employed to bypass this barrier, allowing even a hydrophobic medicinal component to benefit from the special features of gels. Emulgels are dosage forms made up of gels and emulsions that have been mixed. The major goal is to generate a jellified emulsion that will reduce systemic side effects and produce a more prominent effect with fewer drug doses. Thixotropic, greaseless, good Spreadability, easily removable, soothing, soluble in water, long shelf life, bio-friendly, translucent & appealing look are only a few of the benefits of emulgels for dermatological use. As a result, emulgels can be utilize as a good topical drug delivery mechanism than the currently existing traditional systems.","PeriodicalId":8531,"journal":{"name":"Asian Journal of Research in Pharmaceutical Sciences","volume":"18 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-11-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"76465022","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Pulsatile Delivery of Drug for a Range of Diseases 一系列疾病的脉冲给药
Pub Date : 2022-11-22 DOI: 10.52711/2231-5659.2022.00056
Sanket Nikam, Prakash A. Jadhav, B. Chaudhari, A. Velhal
Pulsatile delivery helps in providing the drug at an exact moment based on the disease's pathophysiology that cause improved patient therapeutic efficacy. Drug release rapidly after specific lag time this are advantage for many diseases condition. This system is designed according the body's circadian rhythm and after a lag time, the medication is released fast and totally as a pulse. Pulsatile delivery systems helpful in disease include asthma, arthritis, attention deficient syndrome, peptic ulcer and hypercholesterolemia. These systems are useful for diseases with chrono pharmacological behavior that necessitate nighttime administration, medications with a high first pass effect or GIT site specific absorption, and drugs with a high risk of toxicity or tolerance. By reducing dosing frequency, these devices help increase patient compliance. The foundation for this article is the disease that treat by pulsatile delivery system with drug used for specific disease condition and chrono pharmacology of all disease that mention in article.
脉冲给药有助于根据疾病的病理生理在准确的时刻提供药物,从而提高患者的治疗效果。药物在特定的延迟时间后迅速释放,这对许多疾病的治疗都有好处。该系统是根据人体的昼夜节律设计的,在一段滞后时间后,药物会像脉冲一样快速释放。脉动输送系统对哮喘、关节炎、注意力缺陷综合征、消化性溃疡和高胆固醇血症等疾病都有帮助。这些系统适用于需要夜间给药的慢性药理行为疾病,具有高首过效应或GIT部位特异性吸收的药物,以及具有高毒性或耐受性风险的药物。通过减少给药频率,这些设备有助于提高患者的依从性。本文的研究基础是针对特定疾病情况使用脉冲给药系统治疗的疾病和文中提到的所有疾病的时间药理学。
{"title":"Pulsatile Delivery of Drug for a Range of Diseases","authors":"Sanket Nikam, Prakash A. Jadhav, B. Chaudhari, A. Velhal","doi":"10.52711/2231-5659.2022.00056","DOIUrl":"https://doi.org/10.52711/2231-5659.2022.00056","url":null,"abstract":"Pulsatile delivery helps in providing the drug at an exact moment based on the disease's pathophysiology that cause improved patient therapeutic efficacy. Drug release rapidly after specific lag time this are advantage for many diseases condition. This system is designed according the body's circadian rhythm and after a lag time, the medication is released fast and totally as a pulse. Pulsatile delivery systems helpful in disease include asthma, arthritis, attention deficient syndrome, peptic ulcer and hypercholesterolemia. These systems are useful for diseases with chrono pharmacological behavior that necessitate nighttime administration, medications with a high first pass effect or GIT site specific absorption, and drugs with a high risk of toxicity or tolerance. By reducing dosing frequency, these devices help increase patient compliance. The foundation for this article is the disease that treat by pulsatile delivery system with drug used for specific disease condition and chrono pharmacology of all disease that mention in article.","PeriodicalId":8531,"journal":{"name":"Asian Journal of Research in Pharmaceutical Sciences","volume":"77 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-11-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"75153418","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Pharmacosome as a Vesicular Drug Delivery System 药物小体作为囊状给药系统
Pub Date : 2022-11-22 DOI: 10.52711/2231-5659.2022.00050
R. R. Shinde, B. Chaudhari, A. Velhal, V. Redasani
In the area of solubility enhancement, several problems are encountered. Pharmacosomes are a new technology based on lipid drug carriers. Pharmacosomes are colloidal, vesicles, nanometric size micelles or a hexagonal arrangement of colloidal drug dispersions covalently attached to the phospholipid. Because of their unique properties such as active drug loading, small size, high entrapment efficiency, amphiphilicity and stability, they act as a precise drug carrier. They contribute to the controlled release of medicament at the action site, as well as the reduction of therapy cost, increased bioavailability of poorly soluble drugs, decrease toxicity and drug leakage. There has been an advancement in the scope of this delivery system for a number of drugs used for cancer, heart diseases, inflammation and protein delivery besides with a large number of herbal drugs. Pharmacosomes offer new opportunities and challenges for developing a more effective new vesicular drug delivery system.
在提高溶解度方面,遇到了几个问题。药物小体是一种基于脂质药物载体的新技术。药物小体是胶体、囊泡、纳米大小的胶束或六边形排列的胶体药物分散体,共价附着在磷脂上。由于其具有载药活性强、体积小、包封效率高、亲和性好、稳定性好等特点,是一种精密的药物载体。它们有助于药物在作用部位的控制释放,降低治疗成本,提高难溶性药物的生物利用度,减少毒性和药物泄漏。除了大量的中草药外,这种递送系统的范围已经扩大到许多用于癌症、心脏病、炎症和蛋白质递送的药物。药物体为开发更有效的囊泡给药系统提供了新的机遇和挑战。
{"title":"Pharmacosome as a Vesicular Drug Delivery System","authors":"R. R. Shinde, B. Chaudhari, A. Velhal, V. Redasani","doi":"10.52711/2231-5659.2022.00050","DOIUrl":"https://doi.org/10.52711/2231-5659.2022.00050","url":null,"abstract":"In the area of solubility enhancement, several problems are encountered. Pharmacosomes are a new technology based on lipid drug carriers. Pharmacosomes are colloidal, vesicles, nanometric size micelles or a hexagonal arrangement of colloidal drug dispersions covalently attached to the phospholipid. Because of their unique properties such as active drug loading, small size, high entrapment efficiency, amphiphilicity and stability, they act as a precise drug carrier. They contribute to the controlled release of medicament at the action site, as well as the reduction of therapy cost, increased bioavailability of poorly soluble drugs, decrease toxicity and drug leakage. There has been an advancement in the scope of this delivery system for a number of drugs used for cancer, heart diseases, inflammation and protein delivery besides with a large number of herbal drugs. Pharmacosomes offer new opportunities and challenges for developing a more effective new vesicular drug delivery system.","PeriodicalId":8531,"journal":{"name":"Asian Journal of Research in Pharmaceutical Sciences","volume":"40 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-11-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"85742901","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Preparation and Evaluation of Hydrogel Alginate Beads of Rifaximin 利福昔明海藻酸凝胶珠的制备及评价
Pub Date : 2022-11-22 DOI: 10.52711/2231-5659.2022.00049
Prasad Deshmukh, M. Tawar, Vaishnavi Chandak, Rachana Hallale, Alisha Hirani, Omkar Rajurkar
Any optimal medication delivery system provides a therapeutic amount of medicine to the correct spot in the body to achieve quick reaction and maintain the desired drug concentration. Intravenous drug infusion at the site of action over a desired time period can provide this optimal drug delivery. In recent years, scientists and engineers have developed rate-controlled oral medication delivery devices. These formulations provide the medicine at a controlled and predetermined rate, keeping its therapeutically effective concentration in circulation. Most restricted substances are pills. After carrying out the drug release of prepared hydrogel alginate microbeads, it was discovered that the drug release (%) was found to be in the range of 0.81 to 4.81% for the time period of 03 hours. This finding was made possible by the fact that the drug release (%) was found to be in the range of 0.81 to 4.81%. According to the data on drug release, it was discovered that the batch of fz4 had the highest sustained drug release in comparison to the other batches. According to the pattern of drug release, the rate of drug release slows down as the concentration of polymer in the formulation increases. This formulation prolongs medication release, increasing bioavailability and therapeutic activity. Sodium alginate micro beads with a release modifier could be employed as a medication carrier. The industrial-scale process needs a pilot study.
任何最佳的药物输送系统都可以将治疗量的药物输送到身体的正确部位,以实现快速反应并保持所需的药物浓度。在作用部位静脉输注药物超过一段期望的时间可以提供这种最佳的药物输送。近年来,科学家和工程师已经开发出速率控制的口服药物输送装置。这些配方以受控和预定的速率提供药物,使其在循环中保持治疗有效浓度。大多数受限制的物质是药片。对制备的水凝胶藻酸盐微球进行药物释放后发现,在03小时的时间内,药物释放率(%)在0.81 ~ 4.81%之间。这一发现是由于发现药物释放(%)在0.81 ~ 4.81%的范围内。根据药物释放数据,发现fz4批次相对于其他批次具有最高的持续药物释放。根据药物释放规律,随着制剂中聚合物浓度的增加,药物释放速度减慢。该制剂延长药物释放,增加生物利用度和治疗活性。具有释放调节剂的海藻酸钠微球可作为药物载体。这种工业规模的工艺需要进行初步研究。
{"title":"Preparation and Evaluation of Hydrogel Alginate Beads of Rifaximin","authors":"Prasad Deshmukh, M. Tawar, Vaishnavi Chandak, Rachana Hallale, Alisha Hirani, Omkar Rajurkar","doi":"10.52711/2231-5659.2022.00049","DOIUrl":"https://doi.org/10.52711/2231-5659.2022.00049","url":null,"abstract":"Any optimal medication delivery system provides a therapeutic amount of medicine to the correct spot in the body to achieve quick reaction and maintain the desired drug concentration. Intravenous drug infusion at the site of action over a desired time period can provide this optimal drug delivery. In recent years, scientists and engineers have developed rate-controlled oral medication delivery devices. These formulations provide the medicine at a controlled and predetermined rate, keeping its therapeutically effective concentration in circulation. Most restricted substances are pills. After carrying out the drug release of prepared hydrogel alginate microbeads, it was discovered that the drug release (%) was found to be in the range of 0.81 to 4.81% for the time period of 03 hours. This finding was made possible by the fact that the drug release (%) was found to be in the range of 0.81 to 4.81%. According to the data on drug release, it was discovered that the batch of fz4 had the highest sustained drug release in comparison to the other batches. According to the pattern of drug release, the rate of drug release slows down as the concentration of polymer in the formulation increases. This formulation prolongs medication release, increasing bioavailability and therapeutic activity. Sodium alginate micro beads with a release modifier could be employed as a medication carrier. The industrial-scale process needs a pilot study.","PeriodicalId":8531,"journal":{"name":"Asian Journal of Research in Pharmaceutical Sciences","volume":"28 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-11-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"82004329","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
A Review on Diverging approaches to Fabricate Polymeric Nanoparticles 高分子纳米颗粒制备方法综述
Pub Date : 2022-11-22 DOI: 10.52711/2231-5659.2022.00058
Shivani Deshmukh, B. Chaudhari, A. Velhal, V. Redasani
Polymeric nanoparticles (NPs) are tiny particles with a diameter ranging from of 1 to 1000 nm that can be loaded with active compounds or surface-adsorbed onto the polymeric core. It is novel technology by which we improved therapeutic efficacy, bioavailability of API and better patient compliance. Polymeric NPs have shown promising in the delivery of drug to specific sites for the treatment of a range of disease. Polymeric nanoparticles with a size in the nanometer range protect active substance against degradation in vitro and in vivo, release the drug in a controlled manner, and allow for targeted therapy. The current review discusses polymeric nanoparticle manufacturing methods. Using polymeric drug nanoparticles to improve the therapeutic effectiveness of poorly soluble medicines in any mode of delivery is a universal approach.
聚合物纳米颗粒(NPs)是直径从1到1000纳米不等的微小颗粒,可以装载活性化合物或表面吸附到聚合物核上。这是一项新技术,我们通过它提高了原料药的治疗效果、生物利用度和更好的患者依从性。聚合物NPs在将药物输送到特定部位以治疗一系列疾病方面显示出很大的前景。纳米级大小的聚合纳米颗粒保护活性物质在体内和体外不被降解,以可控的方式释放药物,并允许靶向治疗。综述了高分子纳米颗粒的制备方法。使用高分子药物纳米颗粒来提高任何递送模式下难溶性药物的治疗效果是一种普遍的方法。
{"title":"A Review on Diverging approaches to Fabricate Polymeric Nanoparticles","authors":"Shivani Deshmukh, B. Chaudhari, A. Velhal, V. Redasani","doi":"10.52711/2231-5659.2022.00058","DOIUrl":"https://doi.org/10.52711/2231-5659.2022.00058","url":null,"abstract":"Polymeric nanoparticles (NPs) are tiny particles with a diameter ranging from of 1 to 1000 nm that can be loaded with active compounds or surface-adsorbed onto the polymeric core. It is novel technology by which we improved therapeutic efficacy, bioavailability of API and better patient compliance. Polymeric NPs have shown promising in the delivery of drug to specific sites for the treatment of a range of disease. Polymeric nanoparticles with a size in the nanometer range protect active substance against degradation in vitro and in vivo, release the drug in a controlled manner, and allow for targeted therapy. The current review discusses polymeric nanoparticle manufacturing methods. Using polymeric drug nanoparticles to improve the therapeutic effectiveness of poorly soluble medicines in any mode of delivery is a universal approach.","PeriodicalId":8531,"journal":{"name":"Asian Journal of Research in Pharmaceutical Sciences","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-11-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"85000870","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
β-Cyclodextrin with Sodium Alginate based Nanosponges Preparation and Characterization in the Removal of Organic Toxin: p-Cresol in the Simulated Biological Fluids β-环糊精-海藻酸钠基纳米海绵的制备及其去除模拟生物流体中有机毒素对甲酚的表征
Pub Date : 2022-11-22 DOI: 10.52711/2231-5659.2022.00045
Syed Abdul Azeez, Afreen Sultana, Amtul Hajera
Sodium alginate (SA)-based β-cyclodextrin(β-CD) can show an amazing adsorption capacity and are considered as secure and biocompatible frameworks for evacuating harmful particles from the body. Tyrosine, an amino acid which is found in certain nourishment and food constituents is changed over into p-Cresyl sulfate by intestine microbiota and on the off chance that this cannot be evacuated from the body, it will come-up as a dangerous uremic toxin in the body and rapid removal of this toxic molecule is relevant especially for patients affected by chronic kidney disease. Based on the necessity in the removal of this protein bound uremic toxin, Innovative cyclodextrin polymers were synthesized with different concentrations of sodium alginate to form nanosponges which are able to remove p-Cresol (Phenolic molecule), before it converted into the toxic form i,e,. p-Cresyl sulfate in the body. Furthermore, in vitro studies were carried out using optimal concentrations of sodium alginate with β-cyclodextrin-NS formulations by assessing physicochemical properties, stability, phenol adsorption capacity and in vitro toxicity. Nanosponges (NSs) were found to be of 1:2 proportion of β-cyclodextrin with sodium alginate respectively as NS2-formulation with an adsorption efficiency of in-vitro phenol toxin is 72%. In contrast, this subsidiary was more-steady in gastrointestinal media. In conclusion, this idea proposes that CD-NS details are secure and successful in expelling harmful atoms from the body. Their potential utilization in veterinary or human medication may diminish dialysis recurrence and lead to decreased phenol arrangement which concurrently decreases the cardiovascular and renal burden.
海藻酸钠(SA)基β-环糊精(β-CD)具有惊人的吸附能力,被认为是一种安全的生物相容性框架,可将有害颗粒从体内排出。酪氨酸,一种存在于某些营养和食物成分中的氨基酸通过肠道微生物群转化为对甲酰硫酸盐,如果不能从体内排出,它就会在体内成为一种危险的尿毒症毒素,快速清除这种有毒分子对慢性肾病患者尤为重要。基于去除这种蛋白质结合的尿毒症毒素的必要性,用不同浓度的海藻酸钠合成了创新的环糊精聚合物,形成纳米海绵,能够在对甲酚(酚分子)转化为有毒形式i,e,之前去除对甲酚。对甲酚硫酸盐。此外,通过对海藻酸钠与β-环糊精- ns配方的理化性质、稳定性、苯酚吸附能力和体外毒性的评估,对其进行了最佳浓度的体外研究。结果表明,β-环糊精与海藻酸钠的比例为1:2的纳米海绵对体外酚毒素的吸附效率为72%。相比之下,这种辅助性在胃肠道介质中更为稳定。总之,这一想法表明CD-NS细节是安全的,可以成功地将有害原子从体内排出。它们在兽医或人类用药方面的潜在应用可能会减少透析复发,减少苯酚排列,同时减少心血管和肾脏负担。
{"title":"β-Cyclodextrin with Sodium Alginate based Nanosponges Preparation and Characterization in the Removal of Organic Toxin: p-Cresol in the Simulated Biological Fluids","authors":"Syed Abdul Azeez, Afreen Sultana, Amtul Hajera","doi":"10.52711/2231-5659.2022.00045","DOIUrl":"https://doi.org/10.52711/2231-5659.2022.00045","url":null,"abstract":"Sodium alginate (SA)-based β-cyclodextrin(β-CD) can show an amazing adsorption capacity and are considered as secure and biocompatible frameworks for evacuating harmful particles from the body. Tyrosine, an amino acid which is found in certain nourishment and food constituents is changed over into p-Cresyl sulfate by intestine microbiota and on the off chance that this cannot be evacuated from the body, it will come-up as a dangerous uremic toxin in the body and rapid removal of this toxic molecule is relevant especially for patients affected by chronic kidney disease. Based on the necessity in the removal of this protein bound uremic toxin, Innovative cyclodextrin polymers were synthesized with different concentrations of sodium alginate to form nanosponges which are able to remove p-Cresol (Phenolic molecule), before it converted into the toxic form i,e,. p-Cresyl sulfate in the body. Furthermore, in vitro studies were carried out using optimal concentrations of sodium alginate with β-cyclodextrin-NS formulations by assessing physicochemical properties, stability, phenol adsorption capacity and in vitro toxicity. Nanosponges (NSs) were found to be of 1:2 proportion of β-cyclodextrin with sodium alginate respectively as NS2-formulation with an adsorption efficiency of in-vitro phenol toxin is 72%. In contrast, this subsidiary was more-steady in gastrointestinal media. In conclusion, this idea proposes that CD-NS details are secure and successful in expelling harmful atoms from the body. Their potential utilization in veterinary or human medication may diminish dialysis recurrence and lead to decreased phenol arrangement which concurrently decreases the cardiovascular and renal burden.","PeriodicalId":8531,"journal":{"name":"Asian Journal of Research in Pharmaceutical Sciences","volume":"74 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-11-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"79976933","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Development of Fingerprinting Method for Estimation Glycyrrhizinic acid in Ayurvedic formulation Eladi Gutika: A HPTLC approach hplc法测定阿育吠陀制剂中甘草酸含量的方法研究
Pub Date : 2022-11-22 DOI: 10.52711/2231-5659.2022.00047
T. Jain, A. Vyas, D. Dubey, K. Dashora, Vishal Jain
Eladi gutika is official in Ayurvedic formulary of India and used as a remedy for Kasa (Cough), Svasa (Asthma), Bhrama (Vertigo), Raktapitta (Bleeding disorders), Jvara (Fever), Amvata (Rheumatism) etc. The present paper is an effort to develop the routine fingerprinting method for quality control parameter of Eladi gutika by high performance thin layer chromatography using glycyrrhizinic acid as an internal standard. The HPTLC estimation was carried out with three laboratory batches and one marketed formulation Eladi gutika and crude drug containing glycyrrhizinic acid. The concentration of glycyrrhizinic acid present in raw material was found to be 8.2201±0.497w/w in G. glabra and in three identical laboratory batch of Eladi gutika EG-I, EG -II and EG -III, was found to be 1.4945 ± 0.293, 1.4963 ± 0.763%, 1.4944± 0.864w/w respectively. The glycyrrhizinic acid content in all the three different batches is found to be in close proximities with each other. The results were comparable to marketed formulations. Hence the present method is simple, sensitive, precise and accurate and can be adopted for routine fingerprinting method for quality control of Eladi gutika.
Eladi gutika在印度阿育吠陀处方中是官方的,用于治疗Kasa(咳嗽),Svasa(哮喘),Bhrama(眩晕),Raktapitta(出血性疾病),Jvara(发烧),Amvata(风湿病)等。本文以甘草酸为内标,建立了高效薄层色谱法测定古提卡药材质量控制参数的指纹图谱。对3个实验室批号和1个市售复方艾拉迪古提卡及甘草酸原料药进行hplc鉴别。原料中甘草酸的含量为8.2201±0.497w/w,同一批Eladi gutika EG- i、EG -II和EG -III中甘草酸的含量分别为1.4945±0.293、1.4963±0.763%、1.4944±0.864w/w。三个批次的甘草酸含量基本一致。结果与市场上销售的配方相当。该方法简便、灵敏、精密度高、准确度高,可作为常规指纹图谱方法用于枇杷香的质量控制。
{"title":"Development of Fingerprinting Method for Estimation Glycyrrhizinic acid in Ayurvedic formulation Eladi Gutika: A HPTLC approach","authors":"T. Jain, A. Vyas, D. Dubey, K. Dashora, Vishal Jain","doi":"10.52711/2231-5659.2022.00047","DOIUrl":"https://doi.org/10.52711/2231-5659.2022.00047","url":null,"abstract":"Eladi gutika is official in Ayurvedic formulary of India and used as a remedy for Kasa (Cough), Svasa (Asthma), Bhrama (Vertigo), Raktapitta (Bleeding disorders), Jvara (Fever), Amvata (Rheumatism) etc. The present paper is an effort to develop the routine fingerprinting method for quality control parameter of Eladi gutika by high performance thin layer chromatography using glycyrrhizinic acid as an internal standard. The HPTLC estimation was carried out with three laboratory batches and one marketed formulation Eladi gutika and crude drug containing glycyrrhizinic acid. The concentration of glycyrrhizinic acid present in raw material was found to be 8.2201±0.497w/w in G. glabra and in three identical laboratory batch of Eladi gutika EG-I, EG -II and EG -III, was found to be 1.4945 ± 0.293, 1.4963 ± 0.763%, 1.4944± 0.864w/w respectively. The glycyrrhizinic acid content in all the three different batches is found to be in close proximities with each other. The results were comparable to marketed formulations. Hence the present method is simple, sensitive, precise and accurate and can be adopted for routine fingerprinting method for quality control of Eladi gutika.","PeriodicalId":8531,"journal":{"name":"Asian Journal of Research in Pharmaceutical Sciences","volume":"20 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-11-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"81945018","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
A Novel Tool for Controlled Delivery: Transdermal Drug Delivery System 一种新的控制给药工具:经皮给药系统
Pub Date : 2022-11-22 DOI: 10.52711/2231-5659.2022.00052
A. V. Panval, B. Chaudhari, A. Velhal, V. Redasani
Transdermal Drug Delivery Systems comes under the category of Controlled drug delivery. The main goal of TDDS is to deliver the drug through skin into systemic circulation at controlled rate. TDDS is used to overcome the problems faced during drug administration through oral route. TDDS offers various advantages over different types of drug delivery like oral, IV etc. it provides control release of drug, avoids first pass metabolism, improves bioavailability, better patient compliance and many more. Drug with small molecules can be easily given by transdermal route. These Transdermal patches represents key outcome for growth in skin science and technology. This Review article explains all the detailed information of introduction of TDDS, its advantages and disadvantages, skin and drug permeation and its principle, contents of Transdermal patches it's types and evaluation test.
经皮给药系统属于受控给药范畴。TDDS的主要目标是将药物以可控的速率通过皮肤进入体循环。TDDS用于克服口服给药过程中所面临的问题。与口服、静脉等不同类型的药物递送相比,TDDS提供了各种优势,它提供了药物的控制释放,避免了第一次通过代谢,提高了生物利用度,更好的患者依从性等等。小分子药物容易经皮给药。这些透皮贴片代表了皮肤科学和技术发展的关键成果。本文详细介绍了TDDS的介绍、优点和缺点、透皮贴剂的透皮透药原理、透皮贴剂的内容、类型和评价试验。
{"title":"A Novel Tool for Controlled Delivery: Transdermal Drug Delivery System","authors":"A. V. Panval, B. Chaudhari, A. Velhal, V. Redasani","doi":"10.52711/2231-5659.2022.00052","DOIUrl":"https://doi.org/10.52711/2231-5659.2022.00052","url":null,"abstract":"Transdermal Drug Delivery Systems comes under the category of Controlled drug delivery. The main goal of TDDS is to deliver the drug through skin into systemic circulation at controlled rate. TDDS is used to overcome the problems faced during drug administration through oral route. TDDS offers various advantages over different types of drug delivery like oral, IV etc. it provides control release of drug, avoids first pass metabolism, improves bioavailability, better patient compliance and many more. Drug with small molecules can be easily given by transdermal route. These Transdermal patches represents key outcome for growth in skin science and technology. This Review article explains all the detailed information of introduction of TDDS, its advantages and disadvantages, skin and drug permeation and its principle, contents of Transdermal patches it's types and evaluation test.","PeriodicalId":8531,"journal":{"name":"Asian Journal of Research in Pharmaceutical Sciences","volume":"81 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-11-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"78109308","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Analytical methods to detect the Adulterants in Milk - An Overview 牛奶中掺假物检测的分析方法综述
Pub Date : 2022-11-22 DOI: 10.52711/2231-5659.2022.00046
Varalakshmi Avula, S. P, S. B., K. M
Milk contains whole nutrients and is consumed by the majority of population in the form of drinking as well as dietary products. Milk adulteration is one of the most common phenomena, this milk adulteration can be over looked in many countries. it shows serious health hazards leading to fatal diseases. Milk adulterants have been reported globally by adding various instances such as adding water, whey proteins, melamine, urea, detergents, starch hydrogen peroxide, boric acid. This paper presents a detailed review of common milk adulterants as well as different methods such as the chromatographic methods such as HPLC and GC coupled with mass spectrometry to detect the adulterants in milk, and immunological techniques such as ELISA and various DNA based procedures like PCR have also been used to detect the adulterants both qualitatively and quantitatively. This study is organized to be an adulterants-based study instead of a techniques-based one, where qualitative detection for most of the common adulterants are enlisted and quantitative detection methods are limited to a few major adulterants of milk. Apart from regular techniques, recent development in these detection techniques has also been reported. Nowadays milk is being adulterated in more sophisticated ways that demand for cutting- edge research for the detection of adulterants. This review intends to contribute towards the common knowledge base regarding possible milk adulterants and their detection techniques.
牛奶含有全部营养成分,大多数人以饮用和膳食产品的形式消费。牛奶掺假是最常见的现象之一,这种牛奶掺假在许多国家都可以被忽视。它显示了严重的健康危害,导致致命的疾病。牛奶掺假已在全球范围内报道,通过添加各种实例,如添加水,乳清蛋白,三聚氰胺,尿素,洗涤剂,淀粉过氧化氢,硼酸。本文详细介绍了牛奶中常见的掺假物质,以及各种检测掺假物质的方法,如HPLC和GC结合质谱等色谱方法,以及ELISA等免疫学技术和各种基于DNA的方法如PCR等也已被用于对掺假物质进行定性和定量检测。本研究是一项以掺假为基础的研究,而不是以技术为基础的研究,其中对大多数常见掺假进行定性检测,定量检测方法仅限于几种主要的牛奶掺假。除常规技术外,还报道了这些检测技术的最新发展。如今,人们在牛奶中掺假的方法越来越复杂,这就要求对掺假物的检测进行尖端的研究。这篇综述旨在对可能的牛奶掺假及其检测技术的共同知识库做出贡献。
{"title":"Analytical methods to detect the Adulterants in Milk - An Overview","authors":"Varalakshmi Avula, S. P, S. B., K. M","doi":"10.52711/2231-5659.2022.00046","DOIUrl":"https://doi.org/10.52711/2231-5659.2022.00046","url":null,"abstract":"Milk contains whole nutrients and is consumed by the majority of population in the form of drinking as well as dietary products. Milk adulteration is one of the most common phenomena, this milk adulteration can be over looked in many countries. it shows serious health hazards leading to fatal diseases. Milk adulterants have been reported globally by adding various instances such as adding water, whey proteins, melamine, urea, detergents, starch hydrogen peroxide, boric acid. This paper presents a detailed review of common milk adulterants as well as different methods such as the chromatographic methods such as HPLC and GC coupled with mass spectrometry to detect the adulterants in milk, and immunological techniques such as ELISA and various DNA based procedures like PCR have also been used to detect the adulterants both qualitatively and quantitatively. This study is organized to be an adulterants-based study instead of a techniques-based one, where qualitative detection for most of the common adulterants are enlisted and quantitative detection methods are limited to a few major adulterants of milk. Apart from regular techniques, recent development in these detection techniques has also been reported. Nowadays milk is being adulterated in more sophisticated ways that demand for cutting- edge research for the detection of adulterants. This review intends to contribute towards the common knowledge base regarding possible milk adulterants and their detection techniques.","PeriodicalId":8531,"journal":{"name":"Asian Journal of Research in Pharmaceutical Sciences","volume":"36 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-11-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"81167912","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 3
A Review on in situ Gel of Gastro Retentive Drug Delivery System 胃保留性给药系统原位凝胶研究进展
Pub Date : 2022-11-22 DOI: 10.52711/2231-5659.2022.00054
Bhagyashri V. Aiwale, Bharatee P. Chaudhari, Atish B. Velhal, Vivekkumar K. Redasani
The ‘in situ gel’ system has appeared as one of the most effective drug delivery systems. Its specific distinguishing feature of 'Sol to Gel' transition aids in the continuous and controlled release of medicines. These systems have a number of advantages, including simple production, convenience of use, enhanced adherence, and patient comfort by lowering drug delivery frequency due to their distinctive sol to gel transition characteristics. An in-situ gelling system is a formulation that is in solution form before penetrating the body but transforms to gel form under specified physiological conditions. This review mainly focused on introduction, Advantages and Disadvantages of in situ gel, mechanism, types of Polymers used, Evaluation of in situ gel and its applications.
“原位凝胶”系统已成为最有效的给药系统之一。其“溶胶到凝胶”过渡的特殊特征有助于药物的连续和可控释放。这些系统具有许多优点,包括生产简单,使用方便,增强依从性,由于其独特的溶胶-凝胶过渡特性,通过降低给药频率,使患者感到舒适。原位胶凝系统是一种在进入人体之前呈溶液形式,但在特定生理条件下转化为凝胶形式的制剂。本文主要综述了原位凝胶的介绍、优缺点、机理、聚合物类型、原位凝胶的评价及其应用。
{"title":"A Review on in situ Gel of Gastro Retentive Drug Delivery System","authors":"Bhagyashri V. Aiwale, Bharatee P. Chaudhari, Atish B. Velhal, Vivekkumar K. Redasani","doi":"10.52711/2231-5659.2022.00054","DOIUrl":"https://doi.org/10.52711/2231-5659.2022.00054","url":null,"abstract":"The ‘in situ gel’ system has appeared as one of the most effective drug delivery systems. Its specific distinguishing feature of 'Sol to Gel' transition aids in the continuous and controlled release of medicines. These systems have a number of advantages, including simple production, convenience of use, enhanced adherence, and patient comfort by lowering drug delivery frequency due to their distinctive sol to gel transition characteristics. An in-situ gelling system is a formulation that is in solution form before penetrating the body but transforms to gel form under specified physiological conditions. This review mainly focused on introduction, Advantages and Disadvantages of in situ gel, mechanism, types of Polymers used, Evaluation of in situ gel and its applications.","PeriodicalId":8531,"journal":{"name":"Asian Journal of Research in Pharmaceutical Sciences","volume":"43 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-11-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"72625783","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
期刊
Asian Journal of Research in Pharmaceutical Sciences
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1